NCT03155217View on ClinicalTrials.gov

Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old

CompletedOBSERVATIONAL
Enrollment

358

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2018

Conditions
Metastatic Melanoma
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
collaborator

Saint-Louis Hospital, Paris, France

OTHER

lead

University Hospital, Montpellier

OTHER

NCT03155217 - Tolerance of Targeted Therapy Used in Metastatic Melanoma in Patients Aged Over 65 and 75-year-old | Biotech Hunter | Biotech Hunter